Introduction
Chronic lymphocytic leukemia (CLL) is characterized by immunodeficiency of which hypogammaglobulinemia is the most clinically obvious.(1) However, profound defects in cell-mediated immunity are also a feature of this disease and patients usually have abnormalities in T cell numbers and function. (2) (3) (4) (5) Treatment with chemotherapy appears to exacerbate this problem by inducing T lymphopenia thereby rendering patients more susceptible to infection. (6) A number of recent studies have shown abnormalities in the phenotype of CD4 and CD8 T cells, including inversion of the normal CD4:CD8 ratio (2) (3) (4) (5) and the accumulation of terminally differentiated effector memory T cells with relative absence of naive precursors. (7, 8) By definition, these memory T cells are derived from antigen exposure and it would appear that repeated or chronic antigen stimulation is a feature of this disease. In keeping with this notion, markers of chronic activation are increased on both the CD8 + and CD4 + T cell subsets in CLL patients compared to normal controls. (9) Precisely what antigen(s) are involved in this process remains unresolved, but a number of groups have suggested that cytomegalovirus (CMV) may play a role in driving CD4 + and CD8 + effector memory T cells. (5, 10, 11) However, CMV accounts for a relatively small number of the total T cell count and CMV seronegative individuals still manifest T cell expansion. (5) Although the exact mechanism by which T cells accumulate in CLL is not well defined, T cells derived from patients with advanced disease have shorter telomeres suggesting that these T cells are in some way reacting to the growth of the CLL clone. (12) Consistent with this idea, a number of groups have identified a population of anti- Here we describe the most detailed, large scale, immunophenotypic analysis ever performed on treatment naïve, early stage CLL patients. We demonstrated a skewed distribution of T cell subsets and a preferential expansion of terminally differentiated CD8 + T cells in CLL. Strikingly when patients were stratified into those with inverted (CLL IR ) and normal (CLL NR ) CD4:CD8 ratios, we observed that the CLL IR group had a preferential expansion of CD8 + PD-1 + T cells expressing other markers consistent with replicative senescence. These same patients demonstrated significantly poorer prognosis suggesting that a loss of immunological control has the capacity to alter the pathology of CLL.
Research. 
Antibodies
The following pre -titrated antibodies were used in this study: anti-CD56-FITC, CD16 -APC, CD57-FITC (Serotec), CD5-PE-Cy5.5, CD45RO-APC (Invitrogen), CD19-PE-Cy7, CD27-PE-Cy7, FoxP3-FITC (eBioscience), CD8-APC-Cy7, CD4-Pacific blue, CD3-AmCyan, TCRγδ-APC, CD28-percp-cy5.5 (BD Biosciences), CCR7-PE (RnD Systems), CD25-PE (Miltenyi Biotec) and PD-1-FITC (BD Biosciences).
Immunofluorescent staining and flow cytometric analysis
Direct immunofluorescent staining was performed by adding conjugated antibodies to cells for 15 minutes at 4 o C in the dark, before being washed twice with 1% FCS-PBS.
Between 5x10 5 to 1.5x10 6 1% FCS-PBS and stained for 30 minutes on ice with the surface cell markers: CD25-PE, CD45RA-APC, CD4-Pacific blue, and CD3-AmCyan. Cells were washed twice with 500μl cold 1% FCS-PBS. FOXP3 staining was performed using the FITC anti-human FOXP3 staining kit (eBioscience). Compensation was performed automatically using an antiMouse Ig/Negative control compensation particles set (BD) and FACSDiva software.
Fluorochrome-conjugated monoclonal antibodies (with the same concentration added to the cell samples) were used as single-colour compensation controls. Cells were analysed using a BD FACSCanto II cytometer (BD) and analysis was performed using FlowJo analysis software. Analysis of PBMC by flow cytometry involved the construction of a live lymphocyte gate that was based upon the forward and side scatter profiles of these cells. CD4:CD8 ratios were considered inverted if the ratio was ≤1.0. This threshold was selected based on the median CD4:CD8 ratio of the cohort but also represents the point at which the numbers of CD8 + cells outnumber CD4 + cells.
CMV serostatus
CMV (IgG) serostatus was determined in a blinded fashion by the local Public Health Laboratory Service in a subset of 40 of the patient cohort, 20 inverted ratio samples (CLL IR ) and 20 normal ratio samples (CLL NR ).
Statistics
Non-parametric Mann-Whitney U test was used for comparison of two independent groups. Analysis of prognostic subsets was performed using Fisher's exact test or Chisquare. Time to first treatment and progression-free survival time were calculated from 
Results

Evaluation of peripheral blood lymphocyte populations
As a first step, we compared the frequency of peripheral blood lymphocyte populations in CLL patient samples and age-matched healthy donors (Supplementary Table 1 normal CD4:CD8 ratio (CLL NR ) patients and 10 age-matched healthy controls revealed that, consistent with previous findings,(5) the numbers of both CD4 + and CD8 + T cells were increased in CLL patients compared to normal age-matched controls.
Furthermore, the inverted CD4:CD8 ratio patients showed no evidence of a decline in CD4 + T cell numbers, rather the inversion of the CD4:CD8 ratio was caused by the preferential expansion of CD8 + T cells (Supplementary Table 2 
Comprehensive analysis of T cell subsets in CLL
It is now accepted that a skewed maturation of T cells occurs with ageing and disease, including chronic viral infection. (16) (17) (18) In the first instance, we evaluated whether the frequency of CD4 + and CD8 + memory T cell subsets differed between CLL patients and age-matched controls. The T cell subsets were defined by dividing both the CD4 and CD8 compartments on the basis of CD45RO and CCR7 expression into naïve (CCR7 + CD45RO -), central memory (TCM; CCR7 + CD45RO + ), effector memory (TEM; CCR7 -CD45RO + ) and terminally differentiated effector cells (TEMRA; CCR7 -CD45RO -).
Supplementary Figure 1 shows the gating strategy employed in this study to define T cell subsets. Figure 1A shows that there was a significant reduction in the percentage of naïve CD8 + subsets in CLL patient samples (P=0.0001) with a trend towards an increased frequency of TEM and TEMRA in the CD8 + compartment. Figure 1B shows a similar pattern in the CD4 + compartment; reduced frequency of naïve (P=0.03) and central memory (P = 0.04) subsets and an increase in TEM (P=0.004) and TEMRA subsets (P=0.04). On the basis of these results, the greatest differences in T cell subsets between CLL patients and healthy age-matched controls appear to be found in the CD4 + compartment.
CD8 + cells from patients with Inverted CD4:CD8 ratios have an increased terminal differentiation effector phenotype
A more detailed analysis of our cohort revealed that 47% (52/110) showed a marked preferential expansion of CD8 + cells which resulted in an inversion of the normal CD4:CD8 ratio. We therefore divided our cohort into CLL NR and CLL IR subsets based on a CD4:CD8 ratio threshold of 1.0. This threshold was derived from the median CD4:CD8 ratio for the entire cohort ( Figure 2A ) but a ratio of ≤1.0 also represents the point at which the CD8 compartment becomes larger than the CD4 compartment. We subsequently reanalyzed the T cell subsets in these groups. Figure 2B shows significant reductions in the naïve and central memory CD8 + subsets in CLL IR patients (P=0.002 and P=0.004 respectively) when compared with CLL NR patients. Furthermore, there was a significant increase in the TEMRA subset in the CLL IR group (P=0.03). Figure 2C shows that naïve CD4 cells were also significantly reduced in the CLL IR subset (P=0.0007) with a concomitant increase in TEM (P=0.0005) but not TEMRA (P=0.32) in this compartment. Figures 2D and 2E show the skewing of the CD8 and CD4 subsets in CLL IR and CLL NR samples compared to normal age-matched controls. Most notably, we observed a preferential relative expansion in CD8 + EMRA (P = 0.03) and a concomitant decrease in CD8 + naïve and central memory subsets (P = 0.002 and P = 0.004 respectively) in the CLL IR subset. Consistent with previous findings,(19) the inversion of the CD4:CD8 ratio was not associated with the age of the patients since the median age of the CLL NR and CLL IR subsets were not significantly different (P=0.47).
CLL IR is associated with inferior prognosis in CLL
Intuitively, the increased percentage of effector T cell subsets seen in CLL, particularly in the CLL IR group, might be beneficial either because of increased ability to provide protection against pathogens or perhaps increased immunological control over the tumor cells. Therefore, we evaluated whether an inverted CD4:CD8 ratio had any prognostic relevance in CLL. Contrary to our expectations, the CLL IR group had significantly shorter time to first treatment ( Figure 3A ; P=0.03) and progression-free survival ( Figure 3B ; P=0.005) when compared to the CLL NR group. Therefore, an inverted CD4:CD8 ratio appears to confer an inferior clinical prognosis in this early stage cohort of CLL patients.
Research. In an attempt to rationalize the poor prognosis associated with an inverted CD4:CD8 ratio, we performed a more detailed analysis of the T cell subsets in our cohort. The emergence of a CD57 + CD28 -CD27 -phenotype is associated with replicative senescence and has been observed with ageing and in diseases including CLL. (20) (21) (22) We therefore analyzed CD4 + and CD8 + T cell subsets for the co-expression of CD57, and the absence of CD27 and CD28 to elucidate whether this phenotype was more pronounced in CLL IR and CLL NR patients compared to age-matched healthy donors. Figure 4A shows that a 
CLL IR is not associated with preferential reduction in Tregs
In this study we found a significant increase in Tregs in CLL patients when compared with healthy donors (P=0.03). This is in accordance with previous reports that show that the frequency of Tregs is higher in CLL patients and is further increased in patients with advanced stage disease.(25,26) We therefore analyzed whether there was a significant difference in the frequency of Tregs in CLL IR patients when compared to CLL NR patients ( Figure 6A ). We found no significant difference in the percentage of Tregs in the inverted ratio group (P=0.46) suggesting that changes in Tregs cannot explain the prognostic significance of inverted CD4:CD8 ratios.
CLL IR is not associated with tumor cell phenotype or Binet stage at diagnosis
In order to establish whether there were confounding factors that could explain the prognostic significance of inverted CD4:CD8 ratios in our CLL cohort, we assessed whether there was an association between this phenomenon and known tumor cell prognostic markers (Figures 6B-F) . We found no significant difference in CD38 expression (P=0. 
Discussion
In this study, we performed a comprehensive analysis of T cell subsets in a large cohort of 110 untreated CLL patients. Most of our analysis was based on percentage expression of specific phenotypic subsets but this comparative analysis was also supported by absolute counting data in a subset of the cohort. In keeping with previous studies,(27-31) we found that the T cell subset composition was skewed towards a memory phenotype with a reduced CD4:CD8 ratio in 52% of the patients. Inverted CD4:CD8 ratios have been previously documented in CLL, (2) Instead, they evaluated the CD8:tumor B cell ratio and concluded that higher ratios conferred a good prognosis. This is not surprising given that this ratio is influenced predominantly by the tumor burden, so their findings are not directly comparable to the ones reported in our study.
As reported previously,(32) CD4 + T cell subsets were significantly skewed in our CLL cohort when compared to normal age-matched controls and this was most apparent in the CLL IR subset. However, absolute T cell count analysis of the CLL IR group revealed that the inversion was caused by the preferential expansion of the CD8 + compartment rather than a relative reduction in CD4 + cells (Supplementary Table 2 Our data confirm that CMV seropositivity is a common phenomenon in CLL but it was almost as prevalent in the CLL NR group and so the preferential expansion of CD8 + T cells and the increase in CD58 + CD28 -CD27 -TEMRA in the CLL IR subset cannot be attributed to CMV alone. These findings are in keeping with a recent report that showed CD8 + expansion in CMV seronegative individuals. (12, 14, 36, 37) and this is likely to reflect a composite response against multiple tumor antigens rather than a response restricted to a single Figure 2 Research. 
